Acute Hematologic Toxicity
Acute Hematologic Toxicity is a clinical adverse event category characterized by a rapid-onset, transient disruption in hematopoietic function manifesting as aberrant blood cell counts following exposure to therapeutic or toxic agents.
392
Publications
22.5K
Citations
2.5K
Authors
645
Institutions
Publications per year
2017–2026
53
Parents
392
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text
Medicine, Hematology, Oncology +17
Jorge Romaguera, Luis Fayad, Maria Alma Rodriguez et al. · Journal of Clinical Oncology · 2005 · 559 citations · Full text
Medicine, Oncology, Pharmacotherapy +16
1–5 of 392
2.5K
7
h-index
6
h-index
6
h-index
5
h-index
5
h-index
1–5 of 2.5K
645
The University of Texas MD Anderson Cancer Center
Houston, United States
11 h-index
71 publications
17.6K citations
University of Chicago
Chicago, United States
11 h-index
58 publications
9.4K citations
University of California San Diego
San Diego, United States
10 h-index
45 publications
5.7K citations
National Cancer Institute
Bethesda, United States
9 h-index
18 publications
937 citations
Memorial Sloan Kettering Cancer Center
New York, United States
6 h-index
48 publications
1.7K citations
National Institutes of Health
Bethesda, United States
6 h-index
9 publications
415 citations
University of Illinois Chicago
Chicago, United States
6 h-index
27 publications
6.7K citations
United States Department of Veterans Affairs
Washington, United States
6 h-index
18 publications
1.6K citations
1–8 of 645
Repository · 40 publications · 1.2K citations
22
h-index
25 publications · 1.4K citations
19
h-index
19 publications · 3.2K citations
18
h-index
19 publications · 2.1K citations
17
h-index
11 publications · 1.3K citations
11
h-index
1–5